Form 4 · Filed May 26, 2026, 11:47 PM UTC
RCKT/ROCKET PHARMACEUTICALS, INC.
Shah Gaurav — CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 21, 2026 | M | other | 76,490 | $2 | $129,345 | 1,117,408 |
| May 21, 2026 | S | sell | 55,684 | $3 | $171,841 | 1,061,724 |
| May 21, 2026 | M | other | 76,490 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001140361-26-022894